Cargando…
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
Nanoparticles are heterologous small composites that are usually between 1 and 100 nanometers in size. They are applied in many areas of medicine with one of them being drug delivery. Nanoparticles have a number of advantages as drug carriers which include reduced toxic effects, increased bioavailab...
Autores principales: | Namiot, Eugenia D., Sokolov, Aleksandr V., Chubarev, Vladimir N., Tarasov, Vadim V., Schiöth, Helgi B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821409/ https://www.ncbi.nlm.nih.gov/pubmed/36614230 http://dx.doi.org/10.3390/ijms24010787 |
Ejemplares similares
-
The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs
por: Namiot, Eugenia D., et al.
Publicado: (2023) -
Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials
por: Namiot, Eugenia D., et al.
Publicado: (2022) -
Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials
por: Nazarova, Victoria A., et al.
Publicado: (2022) -
Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
por: Bondarev, Andrey D., et al.
Publicado: (2022) -
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
por: Dahlén, Amelia D., et al.
Publicado: (2022)